Promising drug targets and associated therapeutic interventions in Parkinson’s disease

Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Sachchida Nand, Singh, Payal, Varshney, Ritu, Chaturvedi, Vivek K., Vamanu, Emanuel, Singh, M. P., Singh, Brijesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328771/
https://www.ncbi.nlm.nih.gov/pubmed/33510062
http://dx.doi.org/10.4103/1673-5374.306066
_version_ 1783732366594801664
author Rai, Sachchida Nand
Singh, Payal
Varshney, Ritu
Chaturvedi, Vivek K.
Vamanu, Emanuel
Singh, M. P.
Singh, Brijesh Kumar
author_facet Rai, Sachchida Nand
Singh, Payal
Varshney, Ritu
Chaturvedi, Vivek K.
Vamanu, Emanuel
Singh, M. P.
Singh, Brijesh Kumar
author_sort Rai, Sachchida Nand
collection PubMed
description Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD.
format Online
Article
Text
id pubmed-8328771
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-83287712021-08-09 Promising drug targets and associated therapeutic interventions in Parkinson’s disease Rai, Sachchida Nand Singh, Payal Varshney, Ritu Chaturvedi, Vivek K. Vamanu, Emanuel Singh, M. P. Singh, Brijesh Kumar Neural Regen Res Review Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD. Wolters Kluwer - Medknow 2021-01-25 /pmc/articles/PMC8328771/ /pubmed/33510062 http://dx.doi.org/10.4103/1673-5374.306066 Text en Copyright: © 2021 Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review
Rai, Sachchida Nand
Singh, Payal
Varshney, Ritu
Chaturvedi, Vivek K.
Vamanu, Emanuel
Singh, M. P.
Singh, Brijesh Kumar
Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title_full Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title_fullStr Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title_full_unstemmed Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title_short Promising drug targets and associated therapeutic interventions in Parkinson’s disease
title_sort promising drug targets and associated therapeutic interventions in parkinson’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328771/
https://www.ncbi.nlm.nih.gov/pubmed/33510062
http://dx.doi.org/10.4103/1673-5374.306066
work_keys_str_mv AT raisachchidanand promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT singhpayal promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT varshneyritu promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT chaturvedivivekk promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT vamanuemanuel promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT singhmp promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease
AT singhbrijeshkumar promisingdrugtargetsandassociatedtherapeuticinterventionsinparkinsonsdisease

Ejemplares similares